Monographie - Ceftobiprole medocaril sodium

Ultimele actualizari :
16/12/2025

Ceftobiprole medocaril sodium

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Adaluzis	Irlanda
Mabelio	Franta
Zevtera	Elvetia, Finlanda, Germania, Marea Britanie, Mexic, Norvegia, Peru, Spania, Suedia

Bibliografie : Ceftobiprole medocaril sodium

	tip	publicare
2269	ziar	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3520	Laborator	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3549	Laborator	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laborator	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laborator	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
4650	Laborator	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
5098	ziar	Esteban‑Cartelle B, Anaya B.J, Menéndez‑Conde C.P, Vicente‑Oliveros N , Serrano D.R, Álvarez‑Díaz A. Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices. Infect Dis Ther 2025 ; 14:1685–1696.

Mentions Légales